Golden Valley Development, Inc (GVDI)
USD 0.04
(-30.0%)
USD 0.04
(-30.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -141.81 Thousand USD | -28.92% |
| 2022 | -110 Thousand USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2015 | -3.16 Million USD | -954.17% |
| 2014 | -310.7 Thousand USD | -5350.88% |
| 2013 | -5696.00 USD | 0.0% |
| 2011 | -73.88 Thousand USD | -9.39% |
| 2010 | -67.55 Thousand USD | 62.8% |
| 2009 | -181.56 Thousand USD | -673.99% |
| 2008 | -23.45 Thousand USD | 3.93% |
| 2007 | -24.41 Thousand USD | -10.48% |
| 2006 | -22.1 Thousand USD | -60.09% |
| 2005 | -13.8 Thousand USD | -291.74% |
| 2004 | 5259.00 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -35.79 Thousand USD | 2.99% |
| 2024 Q1 | -36.9 Thousand USD | -4.98% |
| 2023 Q4 | -35.15 Thousand USD | 4.09% |
| 2023 FY | - USD | -28.92% |
| 2023 Q1 | -35.75 Thousand USD | 0.0% |
| 2023 Q2 | -34.25 Thousand USD | 4.2% |
| 2023 Q3 | -36.65 Thousand USD | -7.01% |
| 2022 FY | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2016 Q1 | -1.67 Million USD | 50.58% |
| 2015 Q1 | -97.82 Thousand USD | 89.68% |
| 2015 Q3 | -4460.00 USD | 99.79% |
| 2015 Q4 | -3.37 Million USD | -75667.49% |
| 2015 FY | - USD | -954.17% |
| 2015 Q2 | -2.08 Million USD | -2030.4% |
| 2014 FY | - USD | -5350.88% |
| 2014 Q4 | -947.73 Thousand USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2011 FY | - USD | -9.39% |
| 2010 Q1 | -1843.00 USD | 98.88% |
| 2010 FY | - USD | 62.8% |
| 2010 Q2 | -1843.00 USD | 0.0% |
| 2009 Q1 | -5284.00 USD | -53.65% |
| 2009 Q4 | -164.22 Thousand USD | -3053.89% |
| 2009 FY | - USD | -673.99% |
| 2009 Q3 | -5207.00 USD | 31.93% |
| 2009 Q2 | -7649.00 USD | -44.76% |
| 2008 FY | - USD | 3.93% |
| 2008 Q4 | -3439.00 USD | 50.68% |
| 2008 Q3 | -6973.00 USD | -104.73% |
| 2008 Q2 | -3406.00 USD | 70.59% |
| 2008 Q1 | -11.58 Thousand USD | 44.37% |
| 2007 Q2 | 177.00 USD | 112.81% |
| 2007 Q1 | -1382.00 USD | 47.11% |
| 2007 Q3 | -2413.00 USD | -1463.28% |
| 2007 Q4 | -20.81 Thousand USD | -762.74% |
| 2007 FY | - USD | -10.48% |
| 2006 Q4 | -2613.00 USD | 24.22% |
| 2006 Q2 | -1597.00 USD | 81.76% |
| 2006 Q1 | -8757.00 USD | -399.83% |
| 2006 Q3 | -3448.00 USD | -115.9% |
| 2006 FY | - USD | -60.09% |
| 2005 FY | - USD | -291.74% |
| 2005 Q3 | -5234.00 USD | 28.12% |
| 2005 Q4 | -1752.00 USD | 66.53% |
| 2005 Q2 | -7282.00 USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 85.289% |
| Ansell Limited | 209.86 Million USD | 100.068% |
| Ansell Limited | 206.3 Million USD | 100.069% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 42.83 Million USD | 100.331% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 91.273% |
| Psykey, Inc. | -1.29 Million USD | 89.052% |
| ConvaTec Group Plc | 455.5 Million USD | 100.031% |
| ConvaTec Group Plc | 455.5 Million USD | 100.031% |
| Encision Inc. | -544.19 Thousand USD | 73.941% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -29.0% |
| Innovative MedTech Inc. | -7.67 Million USD | 98.152% |
| LifePoint, Inc. | -14.2 Million USD | 99.001% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 97.708% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 56.366% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | 34.114% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 65.053% |
| SmileDirectClub, Inc. | -186.13 Million USD | 99.924% |
| Sector 10, Inc. | - USD | Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 100.032% |
| SheerVision, Inc. | -110.53 Thousand USD | -28.299% |
| United Health Products, Inc. | -2.5 Million USD | 94.333% |
| Vasamed, Inc. | -4.57 Million USD | 96.9% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 93.727% |
| Yubo International Biotech Limited | -1.17 Million USD | 87.959% |